Physician

Alecia Folkes, DO MS

According to 2025 Medicare claims, Alecia Folkes, DO MS (NPI: 1811358633) practices dermatology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is SKIN AND CANCER ASSOCIATES (NPI: 1427017292; TIN: 65-0008133) and primary practice location at 33071-6040.

Folkes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 377 traditional Medicare patients, billed 1,762 HCPCS/CPT codes, and received $77,042 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 559 prescription claims across 285 beneficiaries totaling $67,517 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 74 records totaling $2,621. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,756 to $67,517. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$80K$160K2022 Medicare payment: $62,109 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $160,117 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $77,042 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222041,054$62,109
20233882,866$160,117
20243771,762$77,042

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$34K$68K2016 Drug cost: $1,756 (USD; Tot_Drug_Cst)2017 Drug cost: $498 (USD; Tot_Drug_Cst)2018 Drug cost: $9,426 (USD; Tot_Drug_Cst)2019 Drug cost: $30,966 (USD; Tot_Drug_Cst)2020 Drug cost: $8,208 (USD; Tot_Drug_Cst)2022 Drug cost: $4,513 (USD; Tot_Drug_Cst)2023 Drug cost: $10,055 (USD; Tot_Drug_Cst)2024 Drug cost: $67,517 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R38$1,756
2017N/R26$498
201878156$9,426
2019182453$30,966
202053119$8,208
2021N/RN/RN/R
202270126$4,513
2023130297$10,055
2024285559$67,517

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more239261$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more113131$67
11102Biopsy of related skin growth, first growth9195$60
17000Destruction of precancer skin growth, 1 growth160177$36
17003Destruction of precancer skin growth, 2-14 growths135766$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil27800$1,763
KetoconazoleKetoconazole932,435$1,455
TacrolimusTacrolimus11300$1,134
Clobetasol PropionateClobetasol Propionate34853$1,070
FluocinonideFluocinonide19540$683

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.74$2,621Dermavant Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alecia Folkes, DO MS?

Tedicare shows public-source Medicare data for Alecia Folkes, DO MS (NPI 1811358633), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alecia Folkes, DO MS have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alecia Folkes, DO MS?

Alecia Folkes, DO MS is linked to SKIN AND CANCER ASSOCIATES (billing NPI 1427017292) in the available physician profile data.

Does Alecia Folkes, DO MS have Open Payments data?

Alecia Folkes, DO MS has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.